Cannabismarketcap

Organigram Holdings Stock Forecast & Price Prediction 2026-2027

Algorithmic price targets and analysis for OGI based on fundamentals, valuation multiples, and historical data.

$0.94-0.43%
Neutral

Price Target Summary

Bear Case
$0.81
-13.5% from current
Base Case
$1.03
+10.0% from current
Bull Case
$1.40
+50.0% from current

Technical Outlook

52-Week Range Analysis

$0.85$2.24
Current: $0.94
Support Level
$0.99
Resistance Level
$2.10
From 52W High
-58.2%
From 52W Low
+9.8%

Fundamental Analysis

Revenue Growth Projection

Year 1 Projected
—
Year 2 Projected
—
Year 3 Projected
—

Not available: trailing revenue is not reported in our data.

Valuation vs Peers

Current P/S
N/A
Sector Median P/S
2.5x
Assessment
N/A

Cash Position

Cash on Hand
N/A
Total Debt
N/A

Key Metrics

Current Price$0.94
Market Cap$131.3M
P/S RatioN/A
Revenue (TTM)N/A
Revenue Growth (YoY)—
Gross MarginN/A
Cash on HandN/A
Total DebtN/A
52W High$2.24
52W Low$0.85

Signal Breakdown

Overall Signal: Neutral
  • Trading more than 50% below 52-week high

Risk Factors

  • Penny stock status (below $1.00) carries heightened volatility and delisting risk.

Analyst Summary

Organigram Holdings (OGI) is a licensed cannabis producer (LP) with a market capitalization of $131.3M. Trailing revenue is not reported in our data, so we can't compare its price-to-sales ratio with the sector median. Our algorithmic base-case price target of $1.03 implies upside of 10.0% from current levels. The overall signal is neutral, with a mixed fundamental picture. Investors should weigh the 1 identified risk factor before making any investment decision.

Frequently Asked Questions

What is the price target for OGI?+
Our algorithmic base-case price target for Organigram Holdings (OGI) is $1.03, with a bear case of $0.81 and a bull case of $1.40. Because trailing revenue is not reported in our data, these targets are simple bands around the current price rather than revenue-based estimates.
Is OGI a buy right now?+
Based on our algorithmic analysis, OGI currently carries a neutral signal. Trading more than 50% below 52-week high. This is not a buy or sell recommendation — always do your own due diligence.
What is the revenue forecast for Organigram Holdings?+
We don't publish a revenue projection for OGI yet because trailing revenue is not reported in our data.
What are the risks of investing in OGI?+
Penny stock status (below $1.00) carries heightened volatility and delisting risk.
How does OGI valuation compare to the cannabis sector?+
OGI has no reported price-to-sales ratio in our data because trailing revenue is not available, so we can't compare it with the cannabis sector median of 2.5x.

Important Disclaimer

This is not financial advice. Forecasts are algorithmic projections based on historical data and should not be used as the sole basis for investment decisions. Past performance does not guarantee future results. Cannabis stocks carry significant risk including regulatory, market, and operational risks. Always consult with a qualified financial advisor before making investment decisions. Cannabismarketcap does not recommend buying, selling, or holding any security.